Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia

British Journal of Cancer

Volumn 93, Issue 2, 2005, Pages 260-265

  Olsen, J H ^a   Hahnemann, J M D ^b   Borresen Dale A L ^c   Tretli, S ^d   Kleinerman, R ^e   Sankila, R ^f   Hammarstrom L ^g   Robsahm, T E ^d   Kaariainen H ^h,i   Bregard A ^c   Brondum Nielsen K ^b   Yuen, J ^j   Tucker, M ^e  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b JOHN F KENNEDY INSTITUTE   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FINNISH CANCER REGISTRY   (Finland)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

more..

Author keywords

ATM heterozygosity; Cancer predisposition; Early onset breast cancer; Familial cancer

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; DENMARK; FAMILY; FEMALE; FINLAND; FOLLOW UP; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NORWAY; PRIORITY JOURNAL; RELATIVE; SWEDEN;

ADULT; AGE FACTORS; AGED; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DENMARK; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; FINLAND; HUMANS; INCIDENCE; LEUCINE ZIPPERS; MIDDLE AGED; NORWAY; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SWEDEN; TUMOR SUPPRESSOR PROTEINS;

EID: 23644442874     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602658     Document Type: Article

References (18)

1. Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134
2. Bailar JC, Ederer F (1964) Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 20: 639-643
3. Bernstein JL, Teraoka S, Haile RW, Borresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P (2003) WECARE Study Collaborative Group. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat 21: 542-550
4. Bianchi DW (2000) Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 91: 22-28
5. Cha D, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson KL (2003) Cervical cancer and michrochimerism. Obstet Gynecol 102: 774-781
6. Easton DF. (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 66(Suppl 6):S177-S182
7. Ewertz M, Duffy SW, Adami HO, Kvale G, Lund E, Meirik O (1990) Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 46: 597-603
8. Geoffroy-Perez B, Janin N, Ossian K, Lauge A, Croquette M-F, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93: 288-293
9. Inskip HM, Kinlen LH, Taylor AMR, Woods CG, Arlett CF (1999) Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 79: 1304-1307
10. Janin N, Andrieu N, Ossian K, Lauge A, Croquette M-F, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D (1999) Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 80: 1042-1045
11. Kumar GK, Al Saadi A, Yang SS, McCaughey RS (1979) Case report: Ataxia-telangiectasia and hepatocellular carcinoma. Am J Med Sci 278: 157-160
12. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lonnqvist T, Kaariainen H, Ladhesmaki A, Yuen J, Tretli S, Heiberg A, Olsen jh, Tucker M, Kleinermann R, Borresen-Dale AL (2000) Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat 16: 232-246
13. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Landmark F, Lanning M, Lie SO, Moe PJ, Moller T, Sankila R, Tulinius H (1993) Second malignant neoplasms after cancer in childhood or adolescence. Br Med J 307:1030-1036
14. Olsen JH, Hahnemann JM, Borresen-Dale A-L, Brondum-Nielsen K, Hammarstrom L, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice Jr JD, Tucker M (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 93: 121-127
15. Robsahm TE, Tretli S (2001) Cutaneous malignant melanoma in Norway: variation by region of residence before and after the age 17. Cancer Causes Control 12: 569-576
16. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831-1836
17. Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J (1992) Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries. APMIS 100(Suppl 31): 3-8
18. Weinstein S, Scottolini AG, Loo SY, Caldwell PC, Bhagavan NV (1985) Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med 109: 1000-1004